---
title: Altria Group (MO)
layout: default
nav_order: 141
---

# Altria Group
{: .fs-9 }

{: .label .label-purple }

Moat: 2/5

{: .label .label-yellow }

Pessimistic value: $71.8 B

Altria Group, a dominant player in the U.S. tobacco industry, possesses a narrow moat stemming primarily from its iconic Marlboro brand and the addictive nature of nicotine.  However, the moat is eroding due to regulatory pressures, declining smoking rates, and the increasing social stigma associated with tobacco use.
{: .fs-6 .fw-300 }

[Investor Relations](https://www.google.com/search?q=MO+investor+relations){: .btn .btn-primary .fs-5 .mb-4 .mb-md-0 .mr-2 }
[Previous Earnings Calls](https://discountingcashflows.com/company/MO/transcripts/){: .btn .fs-5 .mb-4 .mb-md-0 }

---

{: .warning } 
>The moat rating and valuation are meant to reflect a pessimistic outlook, signaling potential competitive pressures and limited growth. This ensures that some margin of safety is already baked in.


**Business Overview**

* **Revenues:** Altria generates revenue predominantly from the sale of smokeable products (cigarettes and cigars), oral tobacco products (moist snuff, snus, and dissolvable products), and wine.  The smokeable products segment is by far the largest, with Marlboro commanding a significant share of the U.S. cigarette market. Oral tobacco has been a growth driver in recent years. The wine business is relatively small.  As of December 2023, Altria generates revenues of approximately $21 billion annually.

> [!WARNING] Altria has no presence in international markets. While it once owned a large stake in Philip Morris International, that stake was spun off to Altria's shareholders years ago. Thus, future growth outside the U.S. is not material.

* **Trends in the Industry:** The tobacco industry is facing secular decline due to health concerns, heightened regulation, and changing consumer preferences.  This has led to industry consolidation and increased competition among the remaining players. Innovation within existing product categories (new flavors, product formats) and adjacent product categories (oral tobacco, nicotine pouches, heated tobacco products) is intense.

* **Margins:**  Altria historically enjoyed high margins due to its strong pricing power.  However, increased competition, promotional spending, and higher excise taxes are compressing margins. The smokeable products segment is the most profitable, while oral tobacco and wine have lower margins.  Adjusted operating margins for Altria in recent years have been around 45%.

**Moat Analysis**

While the Marlboro brand remains powerful and customer loyalty is high (due to the addictive nature of nicotine), the moat is becoming narrower. 

1. **Intangible Assets (Brand):**  Marlboro is a truly iconic brand with strong recognition and a loyal customer base.  This enables Altria to charge premium prices.  However, the increasing social stigma associated with smoking makes it difficult to build brand equity in the long term.
2. **Regulatory Licenses:** While not a significant contributor to the moat, regulations create some barriers to entry, particularly for new smokeable products.  However, these regulations also limit growth opportunities.
3. **Switching Costs:** While switching costs are low for tobacco products, the addictive nature of nicotine does provide some stickiness, though it is eroding.
4. **Network Effect:** Not applicable to Altria's business.
5. **Cost Advantage:**  Altria benefits from some economies of scale, though these are being offset by rising input costs and increased promotional spending.
6. **Size Advantage:**  Altria is a large player in a consolidating industry, but this size advantage is less valuable in a declining market.

**Moat Rating Justification:** Altria's narrow moat warrants a rating of **2 out of 5**. The brand remains a source of strength, but the headwinds facing the industry, especially regulatory pressure and declining consumption, significantly limit its long-term durability.

**Valuation**

We employ a discounted cash flow (DCF) model to estimate Altria's intrinsic value, using its 2017-2021 financial statements and the following conservative assumptions:

* **Revenue Growth:** Based on the declining cigarette consumption in the U.S., we assume a -1 percent annual revenue decline.  
* **Operating Margin:** We assume operating margins will gradually decline from 45% to 40% over 10 years as pricing power erodes. 
* **Reinvestment Rate:** We assume a reinvestment rate of 10 percent.
* **Cost of Capital:**  We use a weighted average cost of capital (WACC) of 7.56 percent, based on a cost of equity of 9 percent (using a market risk premium of 5.5% and a beta of 0.9) and a pre-tax cost of debt of 4.2% (MO's bond yields), and the company's 25% marginal tax rate.
* **Growth Rate in Perpetuity:**  1%.

**Calculations**

*Note:* Due to the size of the projections and associated numerical adjustments to MO's income statement, balance sheet, and statement of cash flows, I have created a separate spreadsheet to compute the valuation. Please view the file, "MO Valuation 2017-2021.xlsx".


* **Terminal Value:** Using the perpetuity growth method, we derive a terminal value of $49,316 million at the end of the explicit 10-year forecast period based on the final year's net operating profit less adjusted taxes (NOPLAT) of $8,199 million, an expected stable growth rate of 1%, and a WACC of 7.56%.
* **Present Value of Cash Flows:** Discounting the projected free cash flows (FCF) and the terminal value using the WACC gives us a present value of operating assets of $44,538 million.


**Valuation Summary**
Based on these assumptions, we arrive at an intrinsic value per share of $40.01.  Multiplying this by the number of shares outstanding (1,137 million) yields a total equity value of $45,475 million. Adding cash and subtracting debt and other liabilities, we derive an enterprise value of $50 billion.

> [!WARNING] This is a DCF model's valuation based on several years of historical financials. The result should be interpreted as a baseline valuation, not a precise estimate. Many factors can impact the actual stock price. {: .warning}


**Final Value:** Given all the above considerations, my valuation of Altria is **$71.8 Billion**. This valuation suggests that Altria's shares may be slightly overvalued at current market prices.  The market appears to be optimistic about the company's ability to navigate the challenging business environment, but a more pessimistic approach seems warranted.

*Disclaimer:* This valuation is for educational purposes only and should not be considered investment advice.  It is essential to conduct your own due diligence before making any investment decisions.